CAS 2095156-13-9

Fórmula: C19H13BClF3N2O4

InChI: InChI=1S/C19H13BClF3N2O4/c21-13-4-7-16(15(9-13)20(28)29)26-18(27)11-1-8-17(25-10-11)30-14-5-2-12(3-6-14)19(22,23)24/h1-10,28-29H,(H,26,27)

Clave InChI: PDMXSCCBEBCTGX-UHFFFAOYSA-N

SMILES: B(C1=C(C=CC(=C1)Cl)NC(=O)C2=CN=C(C=C2)OC3=CC=C(C=C3)C(F)(F)F)(O)O

HSL-IN-1

CAS: 2095156-13-9

Fórmula: C₁₉H₁₃BClF₃N₂O₄

Pureza: 98.84%

Peso molecular: 436.5767

Ref: IN-DA01V71C

HSL-IN-1

CAS: 2095156-13-9

HSL-IN-1 is an HSL inhibitor that significantly reduces the reactive metabolite load and reduces the release of free fatty acids from stored fat.

Fórmula: C₁₉H₁₃BClF₃N₂O₄

Pureza: >99.99%

Forma y color: Solid

Peso molecular: 436.577

Ref: TM-T11576

HSL-IN-1

CAS: 2095156-13-9

HSL-IN-1 is an inhibitor analog of nalbuphine that has shown potential as an anticancer agent. It works by inhibiting the activity of certain kinases that are involved in tumor growth and survival. HSL-IN-1 induces apoptosis, or programmed cell death, in cancer cells by disrupting their protein synthesis and causing DNA damage. This compound has been found to be effective against a variety of human cancers, including breast, lung, and colon cancer. HSL-IN-1 is derived from Chinese medicinal urine and is one of several promising inhibitors currently being studied for their potential use as anticancer agents.

Fórmula: C₁₉H₁₃BClF₃N₂O₄

Pureza: Min. 95%

Peso molecular: 436.6 g/mol

Ref: 3D-VID15613